Skip to content

Discontinued — last reported Q1 '26

Net debt at other companies

Cabot Corporation logo
Cabot CorporationCBT
1.1×-0.3×
Travel + Leisure logo
Travel + LeisureTNL
+1.6×
Unifirst logo
UnifirstUNF
-0.2×-0.1×
HES
Hess MidstreamHESM
3.1×-0.1×
TDA
USA TODAY Co., Inc.TDAY
8.8×+4.2×
Resolute Holdings Management
 logo
Resolute Holdings Management RHLD
11.8×+10.5×

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.4%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%
Debt / equity0.2×
Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's net debt?
Amphastar Pharmaceuticals (AMPH) reported net debt of $515.67M in Q1 2026.
How has Amphastar Pharmaceuticals's net debt changed year-over-year?
Amphastar Pharmaceuticals's net debt increased by 9.7% year-over-year, from $470.13M to $515.67M.
What is the long-term trend for Amphastar Pharmaceuticals's net debt?
Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's net debt has grown at a 81.3% compound annual growth rate (CAGR), from -$24.85M to $486.09M.
What does net debt mean?
Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.